Ciliatech Raises €3.5M in Series A Funding
Ciliatech notes the funds will advance the development of their disruptive glaucoma implant CID and initiate clinical trials in Europe, paving the way for CE mark approval.
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
Ciliatech Raises €3.5M in Series A Funding
Ciliatech notes the funds will advance the development of their disruptive glaucoma implant CID and initiate clinical trials in Europe, paving the way for CE mark approval.